Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ORGANIZATION
ORGANIZATION
- JMA to Call on PAFSC Committee to Review Once Again Switch-OTC of Epadel
November 27, 2012
- 27 JPMA Member Companies’ 1st Half Sales Up 2.1%
November 26, 2012
- JPMA to Compile “Code of Practice,” Eyeing Implementation from April
November 16, 2012
- JPMA Reprimands Mitsubishi Tanabe for GMP Violation by Benesis
November 16, 2012
- JSPE to Introduce Pharmacovigilance Specialist Certification System to Support RMPs
November 14, 2012
- Industry, Academia Launch Project to Raise Public Awareness of COPD
November 1, 2012
- Officials from MOPH of Thailand Receive Quality Control Training: JPMA’s Int’l Cooperation Activities
October 26, 2012
- 1st Graduates Under 6-Year Pharmacy Education System Push Up Percentage of Qualified Pharmacists among Applicants for This Year’s MR Exam: MREAC
October 24, 2012
- Nearly 1,200 Municipalities Cover Full Cost of HPV Vaccinations: Expert Organization Survey
October 23, 2012
- Former Benesis GMP Violation: Ueda Vows to “Root Out” Problems in JBPO
October 19, 2012
- JBPO Looks to Boost Japan’s Self-Sufficiency Ratio of Plasma Derivatives, Mulls Further Integration: Pres. Ueda
October 18, 2012
- Mr Kaiya of Kyokai Kenpo Optimistic About Reaching 30% Generic Drug Use Target
October 18, 2012
- Sino-Japanese Pharmaceutical Exchange Symposium to Be Postponed at Request of China: OPMA
October 15, 2012
- OPMA Temporarily Freezes JBPO’s Appointment as Its Board Member, FPMAJ’s Member of Board of Trustees
October 15, 2012
- Permanent New Drug Premium, Expanded R&D Tax Credits Needed to Encourage Innovation and Investment: FPMAJ Chairman Naito
October 12, 2012
- Price Gap between Long-Listed Products, Generics Necessary: FPMAJ Chairman Naito
October 11, 2012
- President Teshirogi of JPMA Stresses Need for Asian Countries to Cooperate in Drug Discovery
October 11, 2012
- Proposal to Unify Basic Dispensing Fees Could Be Taken Up Again: JPA Vice President Miura
October 10, 2012
- Life Science Budget in Japan Lacks Absolute Amount: JPMA President Teshirogi
October 10, 2012
- “Industry Also Needs to Consider” Distribution of Drug Expenditure: Former Administrative Vice Minister of Health Erikawa
October 5, 2012
ページ
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s FY2026 drug price revision, officially announced on March 5, has landed poorly with the pharmaceutical industry — and the…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…